Current antidiabetic medications aim at decreasing glucose levels, either by improving insulin secretion in the remaining -cells (using insulin secretagogues), by improving the response to insulin in target tissues (using insulin sensitizers), or by replacing the missing insulin (using exogenous insulin treatment)
How to Pack Medications for a Cruise: Complete Rules Guide
Changes coming to weight loss drug coverage benefits, effective January 1, 2025 Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications
Stroke risk factors, genetics, and prevention
Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt
Read More If choosing nutrients for your heart confuses you, youre not alone